August 31, 2014 7:32 AM ET


Company Overview of InCarda Therapeutics, Inc.

Company Overview

InCarda Therapeutics, Inc., a product-focused cardiovascular company, develops transformative therapies for patients to use in the first moments of acute cardiovascular symptoms. It develops an inhaled therapy to treat Paroxysmal atrial fibrillation. The company was formerly known as Pleiades Cardio-Therapeutics, Inc. InCarda Therapeutics, Inc. was incorporated in 2009 and is based in Palo Alto, California.

228 Hamilton Avenue

3rd Floor

Palo Alto, CA 94301

United States

Founded in 2009





Key Executives for InCarda Therapeutics, Inc.

Co-Founder and Executive Chairman
Age: 66
Co-Founder and Chief Scientific Officer
Co-Founder and Chief Medical Officer for Consulting
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Ethos Pharmaceuticals, Inc. United States
McNEIL-PPC, Inc. United States
DiaKine Therapeutics, Inc. United States
Searle & Co. United States
Glycomed Incorporated United States

Recent Private Companies Transactions

Private Placement
September 3, 2013

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact InCarda Therapeutics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at